adenine has been researched along with Nasal Bleeding in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Ibrutinib combined with rituximab is active and well tolerated in patients with relapsed or refractory mantle cell lymphoma." | 2.82 | Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. ( Addison, A; Badillo, M; Champlin, R; Chen, W; Chuang, H; DeLa Rosa, M; Fayad, L; Hagemeister, F; Lam, L; Lee, H; Li, S; Medeiros, LJ; Nomie, K; Oki, Y; Romaguera, J; Samaniego, F; Santos, D; Turturro, F; Wagner-Bartak, N; Wang, ML; Westin, J; Young, KH; Zhang, H; Zhang, L; Zhao, D, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, ML | 1 |
Lee, H | 1 |
Chuang, H | 1 |
Wagner-Bartak, N | 1 |
Hagemeister, F | 1 |
Westin, J | 1 |
Fayad, L | 1 |
Samaniego, F | 1 |
Turturro, F | 1 |
Oki, Y | 1 |
Chen, W | 1 |
Badillo, M | 1 |
Nomie, K | 1 |
DeLa Rosa, M | 1 |
Zhao, D | 1 |
Lam, L | 1 |
Addison, A | 1 |
Zhang, H | 1 |
Young, KH | 1 |
Li, S | 1 |
Santos, D | 1 |
Medeiros, LJ | 1 |
Champlin, R | 1 |
Romaguera, J | 1 |
Zhang, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase II Study of Ibrutinib Plus Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma or Elderly Patients With Newly Diagnosed MCL[NCT01880567] | Phase 2 | 113 participants (Actual) | Interventional | 2013-07-15 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for adenine and Nasal Bleeding
Article | Year |
---|---|
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillatio | 2016 |